Publication | Closed Access
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study
87
Citations
22
References
2020
Year
Week 96Treatment And PreventionAntiviral Drug DevelopmentAntiviral TherapyBrighte StudyPharmacotherapyAntiviral DrugHivMedicinePhase 3
| Year | Citations | |
|---|---|---|
Page 1
Page 1